[go: up one dir, main page]

MX9701187A - Nuevas lactamas naftofusionadas n-substituidas. - Google Patents

Nuevas lactamas naftofusionadas n-substituidas.

Info

Publication number
MX9701187A
MX9701187A MX9701187A MX9701187A MX9701187A MX 9701187 A MX9701187 A MX 9701187A MX 9701187 A MX9701187 A MX 9701187A MX 9701187 A MX9701187 A MX 9701187A MX 9701187 A MX9701187 A MX 9701187A
Authority
MX
Mexico
Prior art keywords
growth hormone
naphthofused
lactams
substituted
novel
Prior art date
Application number
MX9701187A
Other languages
English (en)
Inventor
Henning Thogersen
Birgit Sehested Hansen
Bernd Peschke
Thomas Kruse Hansen
Knud Erik Andersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX9701187A publication Critical patent/MX9701187A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invencion describe nuevas lactamas naftofusionadas N-substituidas y las sales de las mismas de formula (I). Los compuestos de formula general (I) poseen la capacidad de estimular la liberacion de hormona de crecimiento endogena. Así, estos compuestos puede ser usados en el tratamiento de condiciones que requieren la estimulacion de la produccion o secrecion de la hormona de crecimiento, tal como en humanos con deficiencia de hormona de crecimiento, o en donde se desean niveles plasmáticos incrementados en hormona de crecimiento, por ejemplo en pacientes de edad avanzada o en ganado.
MX9701187A 1994-08-17 1995-08-17 Nuevas lactamas naftofusionadas n-substituidas. MX9701187A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK95294 1994-08-17
PCT/DK1995/000332 WO1996005195A1 (en) 1994-08-17 1995-08-17 Novel n-substituted naphthofused lactams

Publications (1)

Publication Number Publication Date
MX9701187A true MX9701187A (es) 1997-05-31

Family

ID=8099355

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701187A MX9701187A (es) 1994-08-17 1995-08-17 Nuevas lactamas naftofusionadas n-substituidas.

Country Status (16)

Country Link
US (1) US5817654A (es)
EP (1) EP0777668A1 (es)
JP (1) JPH10504293A (es)
CN (1) CN1158127A (es)
AU (1) AU697003B2 (es)
BR (1) BR9508805A (es)
CA (1) CA2196877A1 (es)
CZ (1) CZ45897A3 (es)
HU (1) HUT76645A (es)
IL (1) IL114955A (es)
MX (1) MX9701187A (es)
NO (1) NO970684L (es)
PL (1) PL318633A1 (es)
TW (1) TW321640B (es)
WO (1) WO1996005195A1 (es)
ZA (1) ZA956869B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211174B1 (en) * 1997-10-31 2001-04-03 Merck & Co., Inc. Naphtho-fused lactams promote release of growth hormone
US6380184B1 (en) 1998-10-28 2002-04-30 Bristol-Myers Squibb Co. Benzoazepines and analogs thereof useful as growth hormone secretagogues
KR100699404B1 (ko) 1999-02-18 2007-03-23 가켄 세야쿠 가부시키가이샤 성장 호르몬 분비촉진제로서의 신규 아미드 유도체
US6518292B1 (en) 1999-03-12 2003-02-11 Bristol-Myers Squibb Co. Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
US6525203B1 (en) 1999-03-12 2003-02-25 Bristol-Myers Squibb Company Heterocyclic aromatic compounds useful as growth hormone secretagogues
CN1371391A (zh) * 1999-06-30 2002-09-25 汉密尔顿市医院研究发展有限公司 抑制凝血相关凝血因子的肝素成分
BR0110638A (pt) 2000-05-11 2003-03-25 Bristol Myers Squibb Co Análogos de tetraidroisoquinolina úteis como secretagogos de hormÈnio do crescimento
PL363047A1 (en) * 2000-09-08 2004-11-15 Hamilton Civic Hospitals Research Development Inc. Antithrombotic compositions
AU2002357692A1 (en) 2001-11-09 2003-05-26 Bristol-Myers Squibb Company Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
WO2013190520A2 (en) 2012-06-22 2013-12-27 The General Hospital Corporation Gh-releasing agents in the treatment of vascular stenosis and associated conditions
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions
KR20180114910A (ko) 2016-02-05 2018-10-19 데날리 테라퓨틱스 인크. 수용체-상호작용 단백질 키나제 1의 억제제
PT3552017T (pt) 2016-12-09 2022-05-04 Denali Therapeutics Inc Compostos úteis como inibidores de ripk1
EP4463229A1 (en) 2022-01-12 2024-11-20 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206235A (en) * 1991-03-20 1993-04-27 Merck & Co., Inc. Benzo-fused lactams that promote the release of growth hormone
US5583130A (en) * 1992-09-25 1996-12-10 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone

Also Published As

Publication number Publication date
AU697003B2 (en) 1998-09-24
IL114955A (en) 1999-12-22
CZ45897A3 (en) 1997-10-15
HUT76645A (en) 1997-10-28
NO970684L (no) 1997-04-17
NO970684D0 (no) 1997-02-14
EP0777668A1 (en) 1997-06-11
CN1158127A (zh) 1997-08-27
ZA956869B (en) 1996-04-10
CA2196877A1 (en) 1996-02-22
AU3161895A (en) 1996-03-07
WO1996005195A1 (en) 1996-02-22
TW321640B (es) 1997-12-01
US5817654A (en) 1998-10-06
IL114955A0 (en) 1995-12-08
PL318633A1 (en) 1997-06-23
JPH10504293A (ja) 1998-04-28
BR9508805A (pt) 1998-01-06

Similar Documents

Publication Publication Date Title
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
JO1613B1 (en) Derivatives of n - (3-hydroxy-4-piperidnil) dihydrobenzofuran, dihydro-2u-benzopyran or dihydro-benzodoxine) carboxymide
MX9604378A (es) Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios.
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
DE3684409D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
IE901594L (en) Azaindenes
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
BR0317888A (pt) Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
NO20002702L (no) Tienopyrimidiner
DE69427344D1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
MY121387A (en) Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
MX9805141A (es) Uso de inhibidores del intercambiador celular na+/h+ (nhe) para la preparacion de un farmaco para estimular la respiracion.
PL346143A1 (en) Tan-1057 derivatives
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
MY120530A (en) Combination preparation for use in dementia